With the help of genetically engineered mice whose livers turned into glowing light bulbs, researchers at the Salk Institute for Biological Studies have illuminated the underpinnings of an insidious and growing health concern — type 2 diabetes.
Type 1 diabetes is caused when immune cells attack and destroy the insulin producing beta-cells of the pancreas. Although insulin injections have changed the life of type I diabetics, they neither cure the disease nor prevent its severe complications.
The largest-ever study of treatments for type 2 diabetes has shown that a combination of two blood pressure lowering drugs reduced the risk of death, as well as the risks of heart and kidney disease.
People with type 2 diabetes are more prone to have some heart disease, high blood pressure or stroke. Using a combination of diuretics and ACE inhibitors to manage blood pressure in these people with type 2 diabetes can help protect against heart disease, revealed by researchers in a recent worldwide study known as ADVANCE.
Dietary restrictions or other strategies that limit fat formation might make pancreatic cell transplants more effective, UT Southwestern Medical Center researchers report.
The rate of new cases of Type 1 diabetes in children in Australia — already high compared to other countries — is increasing, according to a new report released by the Australian Institute of Health and Welfare (AIHW).
A new study published on bmj.com today calls for better advice about home blood glucose monitoring for patients with non-insulin dependent (type 2) diabetes.
A multidisciplinary team led by researchers at the University of California, San Diego has determined the structure of a protein found in cells that shows potential as a target for the development of new drugs to treat diabetes.
In response to an article published in the Lancet on 24 August, called Acute myocardial infarction and diabetes, which suggests that heart attack victims are at increased risk of diabetes, Professor Peter Weissberg, Medical Director at the British Heart Foundation (BHF) says:
The University of Illinois at Chicago is one of 16 sites in the United States taking part in the first large-scale study to test a promising approach to lowering blood glucose levels in adults with type 2 diabetes.